Cell-line-specific network models of ER+ breast cancer identify PI3Kα inhibitor sensitivity factors and drug combinations
暂无分享,去创建一个
A. Letai | J. Baselga | R. Albert | J. Montero | J. G. T. Zañudo | Pingping Mao | C. Alcon | Kailey J. Kowalski | Gabriela N. Johnson | Guotai Xu | M. Scaltriti | N. Wagle